Clinical Trial

Improving Genetic Counseling for BRCA+ Mothers

Study acronym: PCS IV
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 27, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Genetic counseling and testing for hereditary breast cancer may reveal that you, and possibly your blood relatives, are at increased risk for the disease across the lifespan. This includes biological children, both male and female. We do not yet know the best ways to educate mothers who have a risk gene (are BRCA+) about whether, when, and how to share genetic information with their children or manage their thoughts and feelings. The purpose of this study is to help mothers make more informed choices about talking with children about hereditary breast cancer, provide them with age-and gender-appropriate information and emotional support, and improve their psychological well-being.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-02-04; most recent amendment 2024-09-25.
Status change: Not Yet Recruiting → Recruiting 2020-10-26
Trial Details
NCT Number NCT04258280
Lead Sponsor Georgetown University
Conditions Breast Cancer
Enrollment 200 participants
Start Date 2020-07-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-27